An Iranian court has ordered the U.S. government to pay over $6.7 billion in compensation to a Swedish company that halted the supply of special dressings and bandages for individuals suffering from a rare skin disorder. This decision came after the U.S. imposed sanctions on Iran, leading to the Swedish company's withdrawal from the Iranian market.
The International Relations Law Court in Tehran issued the order on behalf of 300 plaintiffs, including family members of victims and those physically and emotionally affected by the discontinuation of supplies. The court action was taken in response to the suffering of individuals with Epidermolysis bullosa, a genetic condition that causes painful blisters all over the body and eyes. The disease, often referred to as 'butterfly children,' can be life-threatening, with approximately 20 patients reported to have died following the Swedish company's decision.
